Short term administration of NO after continuous epoprostenol treatment
| Patient |
APm (mm Hg) |
PCWP (mm Hg) | Svo 2(%) |
| Before inhalation of NO | |||
| 1 | 83 | 6 | 64 |
| 2 | 70 | 8 | 64 |
| 3 | 73 | 9 | 51 |
| 4 | 75 | 7 | 62 |
| 5 | 77 | 7 | 61 |
| 6 | 75 | 7 | 61 |
| 7 | 76 | 7 | 62 |
| Mean (SD) | 76 (4) | 7 (1) | 61 (4) |
| After inhalation of NO | |||
| 1 | 85 | 6 | 62 |
| 2 | 83 | 9 | 68 |
| 3 | 74 | 9 | 51 |
| 4 | 84 | 7 | 67 |
| 5 | 75 | 8 | 64 |
| 6 | 78 | 6 | 63 |
| 7 | 75 | 7 | 64 |
| Mean (SD) | 80 (5) | 8 (1) | 62 (6) |
Mean arterial pressure, pulmonary wedge pressure, and mixed venous oxygen saturation did not change significantly after combined administration of epoprostenol and inhalation of NO, though there was a tendency for mixed venous oxygen saturation to rise after short term inhalation of NO.
Apm, mean arterial pressure; PCWP, pulmonary capillary wedge pressure; Svo 2, mixed venous oxygen saturation.